Injection drug users: the overlooked core of the hepatitis C epidemic
- PMID: 16447113
- PMCID: PMC1611492
- DOI: 10.1086/499960
Injection drug users: the overlooked core of the hepatitis C epidemic
Comment on
-
Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities.Clin Infect Dis. 2006 Mar 1;42(5):669-72. doi: 10.1086/499951. Epub 2006 Jan 20. Clin Infect Dis. 2006. PMID: 16447112
References
-
- Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(Suppl 1):S11–9. - PubMed
-
- Hahn JA, Page-Shafer K, Lum PJ, et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis. 2002;186:1558–64. - PubMed
-
- Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556–62. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical